Clinical trial

Weight Loss With Risedronate for Bone Health

NCT03411902

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-06-15

PhasePHASE4

Study timeline

Study start (actual)2018-06-15Date precision: day

Registry last updated2021-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bariatric Surgery Candidateunresolved

Bone Lossunresolved

Weight Lossunresolved

Interventions

Risedronate Sodium 150 MGDRUG · verified · RxNorm: risedronate sodium 150 MG

PlaceboOTHER

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Wake Forest Universitycollaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03411902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.